91̽»¨

All publications

Journal articles

• Morita M, Arshad F, Quayle LA, George CN, Lefley DV, Kalajzic I, Balsubramanian M, Cebe T, Reilly G, Bishop NJ & Ottewell PD (2024) . Bone Reports, 22, 101795-101795.
• Zhou J & Ottewell PD (2024) . Journal of Bone Oncology, 46, 100608-100608.
• Kwan A, Stark K, Allen R, Ottewell P & Muthana M (2024) . Medical Research Archives, 12(6).
• Zhou J, Tulotta C & Ottewell PD (2022) . Expert Reviews in Molecular Medicine, 24.
• Canuas-Landero VG, George CN, Lefley DV, Corness H, Muthana M, Wilson C & Ottewell PD (2021) . Frontiers in Endocrinology, 12.
• Tulotta C, Lefley DV, Moore CK, Amariutei AE, Spicer-Hadlington AR, Quayle LA, Hughes RO, Ahmed K, Cookson V, Evans CA , Vadakekolathu J et al (2021) . npj Breast Cancer, 7(1).
• George C, Lefley D, Canuas-Landero V, Tulotta C, Corness H, Wilson C, Muthana M & Ottewell P (2021) . Bone Reports, 14, 101024.
• Canuas-Landero V, George C, Lefley D, Wilson C & Ottewell P (2021) . Bone Reports, 14, 100899.
• Ottewell PD & Lawson MA (2021) . Journal of Cancer Metastasis and Treatment, 7.
• Bishop RT, Marino S, Carrasco G, Li B, Allen RJ, Sparatore A, Ottewell PD, Mollat P, Sims AH, Capulli M , Wang N et al (2020) . Cancer Letters, 488, 27-39.
• George CN, Canuas-Landero V, Theodoulou E, Muthana M, Wilson C & Ottewell P (2020) . Journal of Bone Oncology, 25, 100317-100317.
• Ran R, Harrison H, Syamimi Ariffin N, Ayub R, Pegg HJ, Deng W, Mastro A, Ottewell PD, Mason SM, Blyth K , Holen I et al (2020) . Oncogene.
• Lefley D, Howard F, Arshad F, Bradbury S, Brown H, Tulotta C, Eyre R, Alférez D, Wilkinson JM, Holen I , Clarke RB et al (2019) . Breast Cancer Research, 21(1).
• Eyre R, Alférez DG, Santiago-Gómez A, Spence K, McConnell JC, Hart C, Simões BM, Lefley D, Tulotta C, Storer J , Gurney A et al (2019) . Nature Communications, 10(1).
• Ottewell P & Wilson C (2019) . Breast Cancer: Basic and Clinical Research, 13.
• Allocca G, Hughes R, Wang N, Brown HK, Ottewell PD, Brown NJ & Holen I (2019) . Journal of Bone Oncology, 17.
• Bishop RT, Marino S, de Ridder D, Allen RJ, Lefley DV, Sims AH, Wang N, Ottewell PD & Idris AI (2019) . Cancer Letters, 450, 76-87.
• Tulotta C, Lefley DV, Freeman K, Gregory WM, Hanby AM, Heath PR, Nutter-Howard F, Wilkinson JM, Spicer-Hadlington AR, Liu X , Bradbury S et al (2019) . Clinical Cancer Research, 25(9), 2769-2782.
• Al-Sahaf S, Hunter KD, Bolt R, Ottewell PD & Murdoch C (2019) . International Journal of Cancer, 144(2), 334-344.
• Quayle LA, Ottewell PD & Holen I (2018) . Clinical and Experimental Metastasis.
• Brown HK, Allocca G, Ottewell PD, Wang N, Brown NJ, Croucher PI, Eaton CL & Holen I (2018) . International Journal of Molecular Sciences, 19(10).
• Tulotta C & Ottewell PD (2018) . Endocrine-Related Cancer, 25(7), R421-R434.
• Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M & Ottewell PD (2017) . Breast Cancer Research, 19.
• Holen I, Lefley DV, Francis SE, Rennicks S, Bradbury S, Coleman RE & Ottewell P (2016) . Oncotarget, 7, 75571-75584.
• Ottewell PD (2016) . Journal of Bone Oncology, 5(3), 124-127.
• Ottewell P, Brown H, Allocca G, Haider MT, Brown N & Holen I (2016) . European Journal of Cancer, 61, S74-S75.
• Wright LE, Ottewell PD, Rucci N, Peyruchaud O, Pagnotti GM, Chiechi A, Buijs JT & Sterling JA (2016) . BoneKEy Reports, 5, 804-804.
• Westbrook JA, Cairns DA, Peng J, Speirs V, Hanby AM, Holen I, Wood SL, Ottewell PD, Marshall H, Banks RE , Selby PJ et al (2016) . Journal of the National Cancer Institute, 108(4).
• Holen I, Walker M, Nutter F, Fowles A, Evans CA, Eaton CL & Ottewell PD (2016) . Clinical & Experimental Metastasis, 33(3), 211-224.
• Wang N, Reeves KJ, Brown HK, Fowles ACM, Docherty FE, Ottewell PD, Croucher PI, Holen I & Eaton CL (2015) . Journal of Experimental and Clinical Cancer Research, 34(1), 124-124.
• Ottewell PD, Wang N, Brown HK, Fowles CA, Croucher PI, Eaton CL & Holen I (2015) . International Journal of Cancer, 137(4), 968-977.
• Holen I, Nutter F, Wilkinson JM, Evans CA, Avgoustou P & Ottewell PD (2015) . Clinical & Experimental Metastasis, 32(7), 689-702.
• Wang N, Docherty F, Brown HK, Reeves K, Fowles A, Lawson M, Ottewell PD, Holen I, Croucher PI & Eaton CL (2015) . The FASEB Journal, 29(8), 3141-3150.
• Quayle L, Ottewell P & Holen I (2015) . Current Cancer Drug Targets, 15(6), 469-480.
• Wilson C, Ottewell P, Coleman RE & Holen I (2015) . BMC Cancer, 15(1).
• Ottewell PD, O’Donnell L & Holen I (2015) . BoneKEy Reports, 4.
• Wang N, Docherty FE, Brown HK, Reeves KJ, Fowles ACM, Ottewell PD, Dear TN, Holen I, Croucher PI & Eaton CL (2014) . J Bone Miner Res, 29(12), 2688-2696.
• Ottewell PD, Wang N, Meek J, Fowles CA, Croucher PI, Eaton CL & Holen I (2014) . Endocrine Related Cancer, 21(5), 769-781.
• Ottewell PD, Wang N, Brown HK, Reeves KJ, Fowles CA, Croucher PI, Eaton CL & Holen I (2014) . Clin Cancer Res, 20(11), 2922-2932.
• David M, Machuca-Gayet I, Kikuta J, Ottewell P, Mima F, Leblanc R, Bonnelye E, Ribeiro J, Holen I, Vales RL , Jurdic P et al (2014) . Journal of Biological Chemistry, 289(10), 6551-6564.
• David M, Machuca-Gayet I, Kikuta A, Ottewell PD, Mima F, Leblanc R, Bonnelye E, Ribeiro J, Holen I, Vales RJ , Jurdic P et al (2014) Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.. Journal of Biological Chemistry, 10(289), 6551-6564.
• Nutter F, Holen I, Brown HK, Cross SS, Evans CA, Walker M, Coleman RE, Westbrook JA, Selby PJ, Brown JE & Ottewell PD (2014) . Endocr Relat Cancer, 21(2), 327-341.
• Rogers TL, Wind N, Hughes R, Nutter F, Brown HK, Vasiliadou I, Ottewell PD & Holen I (2013) . Cell Oncol (Dordr), 36(6), 505-514.
• Holen I, Wang N, Reeves KJ, Fowles AM, Croucher PI, Eaton CL & Ottewell PD (2012) . Poster Discussion Abstracts.
• Brown HK, Ottewell PD, Evans CA, Coleman RE & Holen I (2012) A single administration of combination therapy inhibits breast tumour progress bone and modifies both osteoblasts and osteoclasts. Journal of Bone Oncology, 1(2), 47-56.
• Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M & Ottewell PD (2012) . Breast Cancer Res, 14(3), R86.
• Brown HK, Ottewell PD, Evans CA & Holen I (2012) . Clin Exp Metastasis, 29(8), 927-938.
• Ottewell PD, Brown HK, Jones M, Rogers TL, Cross SS, Brown NJ, Coleman RE & Holen I (2012) . Breast Cancer Res Treat, 133(2), 523-536.
• Ottewell PD, Whitworth J, Cross SS, Nutter FH & Holen I (2011) . Poster Session Abstracts.
• Ottewell PD (2011) . IBMS BoneKEy, 8(1), 41-45.
• Brown HK, Ottewell PD, Coleman RE & Holen I (2011) . J Cell Mol Med, 15(3), 501-513.
• Syddall SP, Ottewell PD & Holen I (2010) . Curr Pharm Des, 16(27), 2988-2997.
• Ottewell PD, Lefley DV, Cross SS, Evans CA, Coleman RE & Holen I (2010) . Int J Cancer, 126(2), 522-532.
• Ottewell PD (2010) Effects of gastrin and its precursor peptides upon intestinal epithelia..
• Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE & Holen I (2009) . Mol Cancer Ther, 8(10), 2821-2832.
• Ottewell PD, Lefley DV, Coleman RE & Holen I (2009) . Poster Session Abstracts.
• Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE & Holen I (2008) . J Natl Cancer Inst, 100(16), 1167-1178.
• Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P & Holen I (2008) . Clin Cancer Res, 14(14), 4658-4666.
• Mönkkönen H, Ottewell PD, Kuokkanen J, Mönkkönen J, Auriola S & Holen I (2007) . Life Sci, 81(13), 1066-1070.
• Ottewell PD, Duckworth CA, Varro A, Dimaline R, Wang TC, Watson AJM, Dockray GJ & Pritchard DM (2006) . Gastroenterology, 130(4), 1169-1180.
• Ottewell PD, Coleman RE & Holen I (2006) . Breast Cancer Res Treat, 96(2), 101-113.
• Keen H, Dekker B, Lyons S, Disley L, Hastings D, Reader A, Ottewell PD, Watson A & Zweit J (2005) . Nucl Med Biol, 4(32), 395-402.
• Dekker B, Keen H, Lyons S, Disley L, Hastings D, Reader A, Ottewell PD, Watson A & Zweit M (2005) . Nucl Med Biol, 3(32), 241-252.
• Ottewell PD, Varro A, Dockray GJ, Kirton CM, Watson AJM, Wang TC, Dimaline R & Pritchard DM (2005) . Am J Physiol Gastrointest Liver Physiol, 288(3), G541-G549.
• Ottewell PD, Watson AJM, Wang TC, Varro A, Dockray GJ & Pritchard DM (2003) . Gastroenterology, 124(5), 1348-1357.
• Pritchard DM, Ottewell PD, Watson AJM, Wang TC & Dockray GJ (2002) . Clinical Science, 103(s47), 43P-43P.
• Ottewell PD, Watson AJM, Wang TC, Dockray GJ & Pritchard DM (2002) Progastrin stimulates murine colonic epithelial mitosis after DNA damage. GUT, 50, A93-A93.
• Pritchard D, Ottewell PD, Watson AJM, Wang TC & Dockray GJ (2002) Progastrin stimulates murine colonic epithelial mitosis after DNA damage. GASTROENTEROLOGY, 122(4), A684-A684.
• Marshman E, Ottewell PD, Potten CS & Watson AJ (2001) . J Pathol, 195(3), 285-292.
• MCMICHAEL D, DAVIES A, MARSHMAN E, OTTEWELL P, JENKINS J & WATSON A (2001) . Gastroenterology, 120(5), A660-A660.
• McMichael DP, Davies A, Marshman E, Ottewell PD, Jenkins JR & Watson AJM (2001) Gene array and knockout mouse analysis of VP-16 induced apoptosis in the murine small intestine. GASTROENTEROLOGY, 120(5), A660-A660.
• (2001) . Gut, 48(90001), 60a-64.
• Puppo M, Valluru MK, Croset M, Ceresa D, Iuliani M, Khan A, Wicinski J, Charafe-Jauffret E, Ginestier C, Pantano F , Ottewell PD et al () . British Journal of Cancer.
• Saleh L, Ottewell PD, Brown JE, Wood SL, Brown NJ, Wilson C, Park C, Ali S & Holen I () . Cancers, 15(8), 2211-2211.
• Kwan A, Howard F, Winder N, Atkinson E, Jailani A, Patel PB, Allen R, Ottewell PD, Shaw GC, Conner J , Wilson C et al () . Future Pharmacology, 2(4), 444-459.
• Zhou J, Down JM, George CN, Murphy J, Lefley DV, Tulotta C, Alsharif MA, Leach M & Ottewell PD () . Cancers, 14(19), 4816-4816.
• Hughes R, Chen X, Cowley N, Ottewell PD, Hawkins RJ, Hunter KD, Hobbs JK, Brown NJ & Holen I () . Cancers, 13(6), 1366-1366.
• Al-Sahaf S, Hendawi NB, Ollington B, Bolt R, Ottewell PD, Hunter KD & Murdoch C () . Frontiers in Oral Health, 2.
• Clezardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, Confavreux CB & Holen I () . Physiological Reviews.
• Ran R, Harrison H, Ariffin NS, Ayub R, Pegg HJ, Deng W, Mastro A, Ottewell PD, Fowles AM, Blyth SMMK , Holen I et al () .
• Haider M-T, Ottewell PD, Brown NJ, Lefley DV & Holen I () . Bone Abstracts.
• Bradbury S, Rennicks S, Evans A, del CBM, Holen I & Ottewell P () . Bone Abstracts.
• Ottewell PD () . IBMS BoneKEy, 9.
• Kwan A, Winder NJ, Atkinson E, Al-Janabi HH, Allen RJ, Hughes R, Moamin MR, Louie R, Evans D, Hutchinson M , Capper DT et al () . Molecular Cancer Therapeutics, molcanther.0748.2020-molcanther.0748.2020.
• Quayle LA, Spicer A, Ottewell PD & Holen I () . Cancers, 13(16), 3922-3922.

Chapters

• Holen I, Saleh L, Ottewell PD & Lawson MA (2022) , Bone Cancer (pp. 35-53). Elsevier
• George C, Michael N & Ottewell PD (2022) , Bone Cancer (pp. 121-128). Elsevier
• Ottewell PD & Quayle LA (2019) In Caplan M (Ed.), Reference Module in Biomedical Sciences Elsevier
• Tulotta C, Groenewoud A, Snaar-Jagalska BE & Ottewell P (2019) , Methods in Molecular Biology (pp. 309-330). Springer New York

Conference proceedings papers

• Saleh L, Ottewell PD, Brown JE, Wood SL, Brown NJ, Wilson C, Park C & Holen I (2020) Preventing the progression of breast cancer bone metastasis by CDK inhibition. BREAST CANCER RESEARCH AND TREATMENT, Vol. 180(2) (pp 537-538)
• Tulotta C, Moore CK, Lefley DV, Amariutei AE, Ahmed K, Spicer-Hadlington AR & Ottewell PD (2020) Inhibition of breast cancer bone metastasis through Interleukin-1B regulated tumour-associated innate immune response. BREAST CANCER RESEARCH AND TREATMENT, Vol. 180(2) (pp 538-539)
• Moamin MR, Monk P, Cox A, Ottewell P, Saint-Pol J, Rubinstein E & Muthana M (2019) . Tumor Biology
• Moamin MR, Monk P, Cox A, Ottewell P, Saint-Pol J, Rubinstein E & Muthana M (2019) . Tumor Biology
• Ottewell PD, Lefley DV, Freeman K, Gregory WM, Hanby AM, Spicer-Hadlington AR, Liu X, Bradbury SM, Hambley L, Allocca G , Cookson V et al (2019) . Poster Session Abstracts
• Hughes R, Ottewell P, Hobbs J, Holen I & Brown NJ (2019) Breast Cancer Metastasis to Bone: The Role of the Perivascular Niche in Regulating Tumour Cell Dormancy. JOURNAL OF VASCULAR RESEARCH, Vol. 56 (pp 17-18)
• (2018) . Breast Cancer Research and Treatment, Vol. 167(1) (pp 309-405)
• Eyre R, Alferez D, Santiago-Gomez A, Spence K, McConnell J, Simoes B, Hart C, Lefley D, Tulotta C, Gurney A , Howell S et al (2017) Targeting IL-1 beta-Wnt signalling to prevent breast cancer colonisation in the bone microenvironment. CLINICAL & EXPERIMENTAL METASTASIS, Vol. 34(8) (pp 493-493)
• Tulotta C, Lefley D, Liu X, Spicer-Hadlington A, Hamley L, Cookson V, Allocca G & Ottewell P (2017) IL-1B signalling regulates breast cancer bone metastasis. CLINICAL & EXPERIMENTAL METASTASIS, Vol. 34(8) (pp 516-516)
• Lefley D, Nutter F, Brown H, Tulotta C, Eyre R, Clarke R, Alferez D, Wilkinson M, Holen I & Ottewell P (2017) Human specific models for studying ER plus ve and ER- ve breast cancer bone metastasis. CLINICAL & EXPERIMENTAL METASTASIS, Vol. 34(8) (pp 516-516)
• Quayle L, Park S, McDonnell DP, Ottewell PD & Holen I (2017) . Poster Session Abstracts
• Ottewell P, Brown H, Allocca G, Haider MT, Brown N & Holen I (2016) The bone microenvironment as a master regulator of tumour cell dormancy in breast cancer - evidence from novel in vivo models. EUROPEAN JOURNAL OF CANCER, Vol. 61 (pp S74-S75)
• Byrne M, Ottewell PD, Holen I, Sanderson T & Cross SS (2012) The Use of p63 in Distinguishing In Situ and Invasive Tumour in the PyMT Mouse Model of Breast Cancer. JOURNAL OF PATHOLOGY, Vol. 228 (pp S38-S38)
• Brown HK, Ottewell PD, Evans CA, Coleman RE & Holen I (2011) . BONE, Vol. 48 (pp S255-S255)
• Ottewell PD, Whitworth J & Holen I (2011) THE ROLE OF PLAKOGLOBIN IN THE INITIATION OF BREAST CANCER METASTASES. ANNALS OF ONCOLOGY, Vol. 22 (pp 32-32)
• Ottewell PD, Brown H, Rogers TL, Lefley DV, Evans AC, Wind N, Cross SS, Brown N, Coleman R & Holen I (2011) PREVENTION OF SPONTANEOUS MAMMARY TUMOUR GROWTH BY SEQUENTIAL ADMINISTRATION OF DOXORUBICIN AND ZOLEDRONIC ACID IN AN IMMUNOCOMPETENT MOUSE MODEL. ANNALS OF ONCOLOGY, Vol. 22 (pp 29-29)
• Ottewell PD, Whitworth J & Holen I (2011) THE ROLE OF PLAKOGLOBIN IN THE INITIATION OF BREAST CANCER METASTASES. ANNALS OF ONCOLOGY, Vol. 22 (pp 32-32)
• Ottewell PD, Brown H, Rogers TL, Lefley DV, Evans AC, Wind N, Cross SS, Brown N, Coleman R & Holen I (2011) PREVENTION OF SPONTANEOUS MAMMARY TUMOUR GROWTH BY SEQUENTIAL ADMINISTRATION OF DOXORUBICIN AND ZOLEDRONIC ACID IN AN IMMUNOCOMPETENT MOUSE MODEL. ANNALS OF ONCOLOGY, Vol. 22 (pp 29-29)
• Wind NS, Brown H, Ottewell PD, Sadej R, Romanska H, Berditchevski F & Holen I (2011) . BONE, Vol. 48(1) (pp S45-S45)
• Brown HK, Ottewell PD, Evans CA, Coleman RE & Nolen I (2011) . BONE, Vol. 48(1) (pp S41-S41)
• Ottewell PD, Brown H, Evans CA, Wind NS, Brown NJ, Coleman RE & Holen I (2011) . BONE, Vol. 48(1) (pp S42-S42)
• Westbrook JA, Peng J, Cairns DA, Ottewell PD, Holen I, Coleman RE, Selby PJ, Banks RE & Brown JE (2011) . BONE, Vol. 48(1) (pp S33-S33)
• Brown HK, Ottewell PD, Evans CA & Holen I (2011) . BONE, Vol. 48(1) (pp S40-S41)
• Holen I, Ottewell PD & Coleman RE (2010) . Poster Session Abstracts
• Ottewell PD, Lefely DV, Cross SS, Coleman RE & Holen I (2010) . BONE, Vol. 47 (pp S317-S317)
• Brown HK, Ottewell PD, Lefely DV, Coleman RE & Holen I (2010) . BONE, Vol. 47 (pp S318-S319)
• Woodward J, Holen I, Lefley D, Ottewell P & Buttle D (2010) Breast cancer-bone marrow stromal cell interactions modify expression of proteolytic enzymes and regulators of bone turnover. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 91(2) (pp A45-A46)
• Ottewell PD, Leftey DV, Coleman RE & Holen I (2009) Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer.. CANCER RESEARCH, Vol. 69(2) (pp 200S-201S)
• Ottewell P, Coleman RE & Holen I (2008) . European Journal of Cancer Supplements, Vol. 6(9) (pp 18-18)
• Ottewell PD, Lefley DV, Coleman RE & Holen I (2008) . BREAST CANCER RESEARCH, Vol. 10 (pp S40-S41)
• Lefley DV, Holen I, Coleman RE & Ottewell PD (2008) . BREAST CANCER RESEARCH, Vol. 10 (pp S40-S40)
• Ottewell P, Croucher P & Holen I (2008) . Cancer Treatment Reviews, Vol. 34 (pp 12-12)
• Ottewell P, Coleman R & Holen I (2008) . Cancer Treatment Reviews, Vol. 34 (pp 19-19)
• Woodward J, Lefley D, Cross N, Ottewell PD, Buttle DJ, Coleman RE & Holen I (2007) Tumour cell-bone marrow stromal cell interactions modify expression of cathepsin K, ADAMTS-15, TIMP-3 and osteoprotegerin (OPG). INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 88(6) (pp A97-A97)
• Ottewell PD, Deux B, Monkkonen H, Cross SS, Coleman RE, Clezardin P & Holen I (2007) Differential effects of doxorubicin and zoledronic acid on intra-osseous vs extra-osseous breast tumour growth in vivo.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 106 (pp S39-S39)
• Ottewell PD, Deux B, Monkkonen H, Coleman RE, Clezardin P & Holen I (2007) Differential effect of doxorubicin and zoledronic acid on intra-osseous vs extra osseous breast tumour growth in vivo. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22(7) (pp 1111-1111)
• Woodward JKL, Lefley DV, Cross NA, Ottewell PD, Battle DJ, Coleman RE & Holen I (2007) Tumour cell-bone marrow stromal cell interactions modify expression of cathepsin K, ADAMTS-15, TIMP-3 and osteoprotegerin (OPG). JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 22(7) (pp 1142-1143)
• Van Pozanki C, Otterwell P, Cross S, Hudis C, Coleman RE & Holen I (2007) Osteoprotegerin (OPG) expression in breast tumors and bone metastases. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, Vol. 22(1) (pp 83-84)
• Cross SS, Ottewell P, Swinscoe M, Majeed AW & Holen I (2006) Osteoprotegerin is strongly expressed in the intratumoural endothelial cells of gastrointestinal carcinomas. JOURNAL OF PATHOLOGY, Vol. 208 (pp 9A-9A)
• Van Poznak C, Ottewell P, Cross S, Hudis C, Coleman RE & Holen I (2006) . Bone, Vol. 38(3) (pp 31-32)
• Ottewell PD, Jones M, Coleman RE & Holen I (2006) Synergistic effects of zoledronic acid and doxorubicin in breast cancer models in vivo. CANCER TREATMENT REVIEWS, Vol. 32 (pp S30-S30)
• Ottewell PD, Jones M, Coleman RE & Holen I (2006) . BREAST CANCER RESEARCH, Vol. 8 (pp S17-S17)
• Ottewell PD, Jones M, Coleman RE & Holen I (2006) Synergistic effects of cytotoxic drugs and anti-resorptive agents in vitro and in vivo.. BREAST CANCER RESEARCH AND TREATMENT, Vol. 100 (pp S290-S290)
• Duckworth CA, Ottewell PD, Dimaline R, Varro A & Pritchard DM (2005) Hypergastrinaemia reduces the severity of dextran sulphate sodium induced colitis and 5-fluorouracil induced mucositis in mice. GUT, Vol. 54 (pp A98-A98)
• Duckworth CA, Ottewell PD, Varro A, Dimaline R & Pritchard DM (2005) Hypergastrinaemia reduces the severity of dextran sulphate sodium induced colitis and 5-fluorouracil induced intestinal mucositis in mice.. GASTROENTEROLOGY, Vol. 128(4) (pp A203-A203)
• Ottewell PD, Watson AJ, Varro A & Pritchard DM (2005) Radiation induces gastrin-CCKB receptor expression in IEC-6 and IEC-18 intestinal epithelial cells. GUT, Vol. 54 (pp A88-A88)
• Przemeck SMC, Ottewell PD, Watson AJM & Pritchard DM (2005) Radiation induces p53 dependent apoptosis in the proliferative zone of mouse gastric epithelium. GUT, Vol. 54 (pp A88-A88)
• Davies A, Ottewell P, McNamara A, Jenkins JR & Watson AJM (2004) Etoposide induced p53-dependent gene expression in the GI tract: Analysis of BIRC3, a candidate gene. GASTROENTEROLOGY, Vol. 126(4) (pp A546-A546)
• Ottewell PD, Varro A, Watson AJM, Dimaline R, Dockray GJ & Pritchard DM (2004) Progastrin stimulates murine colonic epithelial mitosis after DNA damage in the absence of murine amidated gastrin. GASTROENTEROLOGY, Vol. 126(4) (pp A272-A272)
• Ottewell PD, Watson A, Wang T, Dockray G & Pritchard M (2003) Progastrin stimulates murine colonic mitosis after DNA damage via the cyclin D1-cdk4 complex. GASTROENTEROLOGY, Vol. 124(4) (pp A100-A100)
• Ottewell PD, Watson A, Wang T, Varro A, Dockray G & Pritchard M (2003) Elevated plasma concentrations of amidated gastrin cause increased crypt survival in murine intestinal epithelia after Gamma-radiation. GASTROENTEROLOGY, Vol. 124(4) (pp A610-A610)
• Ottewell PD, Watson AJM, Wang TC, Varro A, Dockray GJ & Pritchard DM (2003) Elevated plasma concentrations of amidated gastrin cause increased crypt survival in murine intestinal epithelia after gamma radiation. GUT, Vol. 52 (pp A8-A8)
• Davies A, Ottewell PD, McNamara A, Watson AJM & Jenkins JR (2003) P53 dependent differential expression analysis of etoposide induced stress in the murine small intestine. GUT, Vol. 52 (pp A36-A36)
• Ottewell PD, Watson AJM, Wang TC, Dockray GJ & Pritchard DM (2003) Progastrin stimulates murine colonic mitosis after DNA damage via the cyclin D-cdk4 complex. GUT, Vol. 52 (pp A55-A55)
• McMichael DP, Davies A, Marshman E, Ottewell PD, Jenkins JR & Watson AJM (2001) Knockout mouse and gene array analysis of etoposide induced apoptosis in the murine small intestine. GUT, Vol. 48 (pp A61-A62)
• Arshad F, Lefley D, Madan S, Fernandes J, Bishop N & Ottewell P () . Bone Abstracts
• Bishop N, Kalajzic I, Arshad F, Lefley D, Gossiel F & Ottewell P () . Bone Abstracts

Preprints

• Shah KM, Tattersall L, Hussain A, Macfarlane SC, Williamson A, Acosta-Martin AE, Erler JT, Ottewell PD & Gartland A () , Cold Spring Harbor Laboratory.